Immuno-Oncology Therapies: In-Depth Analysis of the Rapidly Evolving Landscape in Next-Generation Cancer Treatment

2024-03-21

免疫疗法疫苗细胞疗法ASCO会议AACR会议

DUBLIN , March 20, 2024 /PRNewswire/ -- The "Innovation Waves in Immuno-oncology Therapy Development" report has been added to

ResearchAndMarkets.com's offering.

Immuno-oncology (I-O) therapies target tumors by harnessing the host's immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, including monoclonals, antibody-drug conjugates (ADCs), bispecific antibodies, and several therapeutic cancer vaccines, are making rapid strides in clinical trials as effective immunotherapy.

This study discusses the key trends and technologies driving the development of such I-O therapies. It delves into advancements in cancer vaccines and cell therapies for various cancer indications, highlighting some of the innovators in this space.

Next-generation cell therapies, personalized cancer vaccines, and strategic areas of focus have also been discussed in this report. The study examines the factors driving and restraining this industry and identifies the growth opportunities emerging from the changes in this space for market players and stakeholders to leverage.

Key questions answered in this study:

What does the current clinical landscape of I-O therapies look like?

Which are the technology enablers driving the adoption of I-O therapies?

What are the key developments in adoptive cell therapies and cancer vaccines?

What are the roadblocks to successful translation?

What are the research and development (R&D) focus areas?

What are the key focus areas for the future?

Key Growth Opportunities

Growth Opportunity 1: Combination Immunotherapies

Growth Opportunity 2: Precision Oncology

Growth Opportunity 3: Advanced Synthetic Biology Platforms

Growth Opportunity 4: Organoids and Organ-on-Chip Models

Key Topics Covered:

Growth Environment: I-O Therapies

Need for Immunotherapy

Scope of Analysis

Segmentation: Snapshot of I-O Therapies

I-O Therapies in Development

Growth Opportunities in I-O Therapy

Growth Drivers

Growth Restraints

Trends and R&D Focus: I-O Therapies

I-O Technology Trends and Developments

Trends in I-O Therapeutics

Therapeutic Development Trends in I-O

R&D Focus Areas to Boost Immunotherapies

Modulation of TME: Solid Tumor Type Determines Therapy

Developing Effective Preclinical Models for Translation

Stakeholders Developing Preclinical Models for I-O Therapy Evaluation

Holistic Tumor Profiling to Boost Precision Oncology Efforts

Emerging I-O Therapeutic Modality Development Landscape

Quick Facts on I-O Therapies

Clinical Development Landscape of I-O Therapies

Cell Therapy to Create the Next Wave of I-O Developments

Cell Therapy Types: Snapshot

Clinical Development Landscape of I-O Cell Therapies

Emerging Areas of Focus to Improve Functionality and Safety Cell Therapies

Next-generation CAR-T Therapy Development

Priority Areas to Improve the Accessibility of Cell Immunotherapy

Innovative Technologies for Cell Therapy Manufacturing and Delivery

Stakeholders Developing Emerging Next-gen Cell Therapies

Potential of Vaccines to Address Challenges with Difficult-to-Treat Cancers

Cancer Vaccine Types

Personalized Neoantigen Vaccines in Clinical Development

Areas of Focus to Bolster Cancer Vaccine Development

RNA Vaccines to Drive the Wave of Prophylactic and Therapeutic Cancer Vaccines

Road Ahead for Cancer Vaccines and Immunotherapy

Emerging Cancer Vaccine

Impact of Emerging Cancer Vaccines Across Cancers

I-O Stakeholder Ecosystem

Regional Trends in I-O Developments and Adoption

Federal Initiatives and Programs Driving I-O Therapy Development

I-O Deals and Investment Trends

Notable Partnerships and Collaborations in I-O, 2023

I-O Regulatory Environment and Reimbursement

I-O: Current Gaps and Potential Opportunities

Strategies to Improve Access and Care Delivery of I-O Therapies

For more information about this report visit https://www.researchandmarkets.com/r/9og2f0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[email protected]

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets